Tucaxen 150 mg Tablets

Molecule: Tucatinib

Strength: 150 mg

Quantity: 30 Tablets

Form: Tablet

Packaging Type: Bottle

Manufacturer/Marketed By: Everest Pharma

Country of Origin: Bangladesh

Product	Manufacturer / Marketed By	Price
Tucanat 150 mg Tablet	Natco Pharma	Ask for Price
LuciTuca 150 mg Tablet	Lucius Pharma	Ask for Price
Tukysa 150 mg Tablet	Seagen	Ask for Price

Description

Tucaxen Tucatinib Tablets, your trusted ally in advanced cancer treatment. Each bottle contains 30 tablets of Tucatinib, a powerful molecule invented to target specific cancer cells while minimizing impact on healthy tissue. With a strength of 150 mg per tablet, Tucaxen is expertly formulated to enhance your treatment plan. Manufactured by Everest Pharma in Bangladesh, Tucaxen is a generic brand with quality and efficacy. As an innovative therapeutic option, Tukysa—demonstrates remarkable potential in improving outcomes for patients with certain types of cancer. Tucatinib, the active molecule in Tucaxen, works by selectively inhibiting the HER2 receptor, providing a precise mechanism to disrupt cancer cell growth. This targeted action helps improve overall treatment outcomes and enhances the quality of life for patients. With Tucaxen, you’re choosing a reliable and effective solution backed by advanced research and development. Experience the benefits of this groundbreaking therapy and take a confident step towards your health with Tucaxen Tucatinib Tablets. Embrace the potential of Tukysa with Tucaxen, because your journey to wellness matters.

Indications and Usage

HER2-Positive Breast Cancer: Tucatinib is used in combination with other medications, such as trastuzumab and capecitabine, to treat patients with locally advanced or metastatic HER2-positive breast cancer.

Previously Treated Patients: It is particularly indicated for patients who have received one or more prior anti-HER2 therapies, including those who have brain metastases.

Brain Metastases: Tucatinib has shown efficacy in patients with brain involvement, which is a common complication in HER2-positive breast cancer that can complicate treatment options.

Combination Therapy: It is often used in combination with other systemic therapies to enhance anti-tumor activity and improve clinical outcomes in patients with resistant disease.

Targeted Therapy: As a small molecule tyrosine kinase inhibitor, Tucatinib specifically inhibits the HER2 protein, making it effective in targeting tumor cells that overexpress HER2.

Clinical Trials: Tucatinib has been studied in clinical trials, demonstrating improved progression-free survival and overall survival in eligible patient populations compared to traditional therapies.

Patients should discuss their treatment options with their oncologist to determine the appropriateness of Tucatinib based on their specific cancer characteristics and treatment history. As with any medication, it is important to consider potential side effects and interactions with other drugs.

How it Works

Tucatinib is a small molecule tyrosine kinase inhibitor that targets the human epidermal growth factor receptor 2 (HER2). HER2 is a protein that, when overexpressed, promotes the growth and spread of cancer cells, particularly in certain types of breast cancer. By specifically inhibiting HER2 signaling, Tucatinib helps to stop or slow down the growth of HER2-positive tumors. It is particularly effective in treating breast cancer that is resistant to other therapies and has shown effectiveness in treating brain metastases.

Dosage & Administration

Dosage: The recommended dose of Tucatinib is usually 300 mg taken orally twice daily. However, the specific dosage may vary based on individual patient factors and should be directed by a healthcare professional.
Administration: It can be taken with or without food. It’s essential to follow the prescribing physician’s instructions regarding timing and dosage.
Adherence: Patients should adhere to the treatment schedule and consult their healthcare provider if they miss a dose or experience side effects.

Side Effects

Common side effects of Tucatinib may include:

Diarrhea: A frequent side effect that may require management with medications or changes in diet.
Nausea: May occur but is generally manageable.
Fatigue: Many patients report feeling tired or lacking energy.
Rash: Skin rashes or changes can occur.
Appetite Loss: Decreased appetite is a common complaint.
Abdominal Pain: Some patients may experience stomach discomfort.
Elevated Liver Enzymes: Liver function tests should be monitored, as elevated enzymes can indicate liver issues.

Less common but serious side effects may include:

Severe Liver Toxicity: Monitor liver function closely.
Cardiac Issues: Patients with certain pre-existing conditions may need monitoring for heart-related side effects.
Severe Allergic Reactions: Anaphylaxis or severe allergic reactions may occur in rare cases.

Warning and Precaution

Liver Function: Regular monitoring of liver function tests is essential, as Tucatinib can cause liver dysfunction.
Cardiovascular Health: Patients should be assessed for any history of heart problems, as there may be risks associated with cardiac events.
Pregnancy and Lactation: Tucatinib can cause fetal harm; thus, effective contraception is recommended during treatment and for a period after completing therapy. It is also not recommended for breastfeeding mothers.
Drug Interactions: Inform the healthcare provider about all medications, supplements, or herbal products being taken to avoid potential interactions.

FAQ

What is Tucaxen 150 mg used for?+

Tucaxen 150 mg is used in combination with trastuzumab and capecitabine to treat HER2-positive advanced or metastatic breast cancer, particularly in patients who have previously received anti-HER2 therapies.

What are the uses of Tucaxen 150 mg tablets?+

Tucaxen is used to treat HER2-positive breast cancer that has spread to other parts of the body, including the brain. It helps inhibit cancer cell growth by blocking the HER2 receptor.

What is the function of a Tucaxen 150 Tablet?+

Tucaxen contains tucatinib, a tyrosine kinase inhibitor that selectively targets the HER2 receptor on cancer cells, helping to slow or stop tumor growth.

Is Tucaxen the same as Tukysa?+

Yes, Tucaxen is a generic version of Tukysa, both of which contain the active ingredient tucatinib and are used for the same indications.

Can Tucaxen 150 mg be used for brain metastases?+

Yes, Tucaxen is effective in treating HER2-positive breast cancer with brain metastases, as tucatinib can cross the blood-brain barrier.

How is Tucaxen 150 mg taken?+

Tucaxen is usually taken orally twice a day, approximately 12 hours apart, with or without food, as directed by your healthcare provider.